Michael F. Good

Griffith University — Australia

Medicine · Health Sciences

67h-index16.8kcitations444works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(182), Streptococcal Infections and Treatments(145), Mosquito-borne diseases and control(109), Antimicrobial Resistance in Staphylococcus(88), Neonatal and Maternal Infections(74)

Publications444 total

Rapid screening for acute rheumatic fever using machine learning analysis of host tissue reactive antibodies
Scientific Reports·2025Open Access
Phase I Trial of a Peptide-Based Vaccine to Prevent Group A Streptococcal Infection
2025Open Access
Low-Dose Interleukin-2 Therapy: A Transformative Approach for the Management of Autoimmune Complications Associated with Streptococcus pyogenes Infections
2025Open Access
Delineating Humoral and Cellular Immune Responses Induced by a Peptide-Based Vaccine for Protection Against Streptococcus pyogenes
2025Open Access
Human Antibodies to M-Protein Epitope-Based Vaccines Demonstrate Increased Immunogenicity and Streptococcus pyogenes (StrepA) Bactericidal Activity
2025Open Access
Parenteral Vaccination with a Super Immunogen Targeting M-Protein Provides Unprecedented Protection Against Group A Streptococcus (StrepA) Respiratory Infections
2025Open Access
Subclinical exposure to Streptococcus pyogenes drives the development of long-lived immunity
2025Open Access
Sub-clinical exposure to <i>Streptococcus pyogenes</i> drives the development of immunity
2025Open Access
Inflammatory Responses Potentiate GAS M Protein Induced Cardiac Damage in an Experimental Model of Rheumatic Heart Disease
Immunity Inflammation and Disease·2025Open Access
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease
mBio·2025· 1 citedOpen Access
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections
Nature Communications·2024· 9 citedOpen Access
A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteers
Trials·2024· 6 citedOpen Access
Immunotherapeutic strategy to prevent progression and complications of acute rheumatic fever
2024· 1 citedOpen Access
Chimeric hepatitis B surface antigen virus-like particles expressing the strep A epitope p*17 elicit a humoral immune response in mice
Heliyon·2024· 2 citedOpen Access
<i>Streptococcus pyogenes</i> pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections
2024Open Access
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model
Vaccines·2024· 3 citedOpen Access
Disruption of IL-17-mediated immunosurveillance in the respiratory mucosa results in invasive Streptococcus pyogenes infection
Frontiers in Immunology·2024· 5 citedOpen Access
A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4 <sup>+</sup> T-cell-dependent strain-transcending protective immunity in rodent models
mBio·2023· 2 citedOpen Access
Disruption of IL-17 signaling in the respiratory mucosa results in invasive streptococcal infection
2023Open Access
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
Nature Communications·2023· 13 citedOpen Access
page 1 of 23Next →

Frequent Co-authors

Louis H. Miller(10), Jay A. Berzofsky(8), Michael R. Batzloff(6), Isabella A. Quakyi(5), Christian Engwerda(5), Richard A. Houghten(4), Sanjai Kumar(4), Michelle Wykes(4), Sumalee Pruksakorn(4), Evelyn R. Brandt(4), István Tóth(4), Chakrit Hirunpetcharat(3), Bernard Moss(3), L H Miller(3), Huji Xu(3), Mariusz Skwarczyński(3), Fiona H. Amante(3), Geoffrey R. Hill(3), Bart J. Currie(3), Andrew Galbraith(3)